News

Myths of Risk-Based Monitoring

Part 2: The Myth of Technology At Kestrel Biologic, we have collaborated with many sponsors, regulators and CRO’s, and want to highlight the various myths surrounding risk-based monitoring (RBM) in a series of articles. In my first article, I addressed...
Read More

Myths of Risk-Based Monitoring

Part I: The Myth of Reduced SDV I have collaborated with many sponsors, regulators and CRO’s and want to highlight the various myths surrounding risk-based monitoring (RBM) in a series of articles. In this first article, I am going to...
Read More

We Hear You

We have consulted with lots of sponsors in the past 3 months about Risk Based Monitoring. We were amazed by the similarities and degree of the pain points we all face in clinical research. Unfortunately, we have been talking about...
Read More

Season’s Greetings

From all of us at Kestrel Biologic wishing everyone all the best for the holiday season!
Read More

Helping you implement ICH GCP R2 changes with iQROS™ software

Clinical trials have seen significant advances in the technology used since the ICH GCP document was first released. Electronic data recording. Centralized monitoring. The landscape has evolved, and recently the ICH GCP has been updated to align the standards of...
Read More